CN118697931A - A kind of oral repair adhesive imitating mussel mucin and preparation method thereof - Google Patents
A kind of oral repair adhesive imitating mussel mucin and preparation method thereof Download PDFInfo
- Publication number
- CN118697931A CN118697931A CN202410693085.XA CN202410693085A CN118697931A CN 118697931 A CN118697931 A CN 118697931A CN 202410693085 A CN202410693085 A CN 202410693085A CN 118697931 A CN118697931 A CN 118697931A
- Authority
- CN
- China
- Prior art keywords
- hydroxyethyl cellulose
- catechol
- mixed
- repair adhesive
- preparing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 30
- 239000000853 adhesive Substances 0.000 title claims abstract description 29
- 241000237536 Mytilus edulis Species 0.000 title claims abstract description 19
- 235000020638 mussel Nutrition 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims abstract description 49
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims abstract description 49
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims abstract description 35
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 30
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 25
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 19
- 150000005206 1,2-dihydroxybenzenes Chemical class 0.000 claims abstract description 18
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 18
- 239000000194 fatty acid Substances 0.000 claims abstract description 18
- 229930195729 fatty acid Natural products 0.000 claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims abstract description 12
- 239000003054 catalyst Substances 0.000 claims abstract description 11
- 150000002009 diols Chemical class 0.000 claims abstract description 10
- 239000000203 mixture Substances 0.000 claims abstract description 10
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 8
- 238000010992 reflux Methods 0.000 claims abstract description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 claims description 26
- 229960004502 levodopa Drugs 0.000 claims description 26
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 15
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 235000011187 glycerol Nutrition 0.000 claims description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 8
- 235000021314 Palmitic acid Nutrition 0.000 claims description 4
- ALQSHHUCVQOPAS-UHFFFAOYSA-N Pentane-1,5-diol Chemical compound OCCCCCO ALQSHHUCVQOPAS-UHFFFAOYSA-N 0.000 claims description 4
- 235000021355 Stearic acid Nutrition 0.000 claims description 4
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 4
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 4
- 239000008117 stearic acid Substances 0.000 claims description 4
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical group OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 abstract description 12
- 230000002209 hydrophobic effect Effects 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- 239000000227 bioadhesive Substances 0.000 abstract 1
- 230000035484 reaction time Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 208000025865 Ulcer Diseases 0.000 description 8
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000007117 Oral Ulcer Diseases 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 239000008367 deionised water Substances 0.000 description 4
- 229910021641 deionized water Inorganic materials 0.000 description 4
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical group CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- JUHDUIDUEUEQND-UHFFFAOYSA-N methylium Chemical compound [CH3+] JUHDUIDUEUEQND-UHFFFAOYSA-N 0.000 description 4
- 239000012074 organic phase Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 238000007142 ring opening reaction Methods 0.000 description 4
- 238000013517 stratification Methods 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 3
- 208000002399 aphthous stomatitis Diseases 0.000 description 3
- 238000004132 cross linking Methods 0.000 description 3
- 125000003700 epoxy group Chemical group 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000000269 nucleophilic effect Effects 0.000 description 2
- 239000012434 nucleophilic reagent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-UHFFFAOYSA-N Dopaquinone Natural products OC(=O)C(N)CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AHMIDUVKSGCHAU-LURJTMIESA-N L-dopaquinone Chemical compound [O-]C(=O)[C@@H]([NH3+])CC1=CC(=O)C(=O)C=C1 AHMIDUVKSGCHAU-LURJTMIESA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 238000005815 base catalysis Methods 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- -1 carbon cations Chemical class 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/08—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/001—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Dental Preparations (AREA)
Abstract
本发明公开了一种仿贻贝粘蛋白的口腔修复粘结剂及其制备方法,属于生物粘附材料技术领域。所述制备方法包括以下步骤:羟乙基纤维素与甘油混合并加热至45~50℃,再加入邻苯二酚衍生物与其混合搅拌形成反应体系;向所述反应体系中加入碱性催化剂后,在60~70℃下反应时间2~4h得到混合物;所述混合物经与所述碱性催化剂的等量的盐酸处理后与脂肪酸、二元醇混合,再加入浓盐酸加热回流得到邻苯二酚‑羟乙基纤维素衍生物;所述邻苯二酚‑羟乙基纤维素衍生物与水性丙烯酸固化剂按照质量比3:1混合搅拌得到所述口腔修复粘结剂。本发明通过共价结合将邻苯二酚衍生物的邻苯二酚结构和脂肪酸的疏水侧链结合到羟乙基纤维素上,实现了对羟乙基纤维素的口腔粘结性能的改善。The invention discloses an oral repair adhesive imitating mussel mucin and a preparation method thereof, and belongs to the technical field of bioadhesive materials. The preparation method comprises the following steps: hydroxyethyl cellulose is mixed with glycerol and heated to 45-50°C, and then a catechol derivative is added and mixed with it to form a reaction system; after adding an alkaline catalyst to the reaction system, a mixture is obtained at 60-70°C for a reaction time of 2-4h; the mixture is treated with an equal amount of hydrochloric acid with the alkaline catalyst, and then mixed with fatty acids and diols, and then concentrated hydrochloric acid is added and heated to reflux to obtain a catechol-hydroxyethyl cellulose derivative; the catechol-hydroxyethyl cellulose derivative is mixed with an aqueous acrylic acid curing agent in a mass ratio of 3:1 to obtain the oral repair adhesive. The present invention combines the catechol structure of the catechol derivative and the hydrophobic side chain of the fatty acid to the hydroxyethyl cellulose through covalent bonding, thereby achieving an improvement in the oral bonding performance of the hydroxyethyl cellulose.
Description
技术领域Technical Field
本发明属于生物粘附材料技术领域,具体涉及根据贻贝粘蛋白的高强度耐水粘附特性,开发出的一种仿贻贝粘蛋白的口腔修复粘结剂及其制备方法。The invention belongs to the technical field of biological adhesive materials, and in particular relates to an oral repair adhesive imitating mussel mucin, which is developed according to the high-strength water-resistant adhesive property of mussel mucin and a preparation method thereof.
背景技术Background Art
口腔溃疡是一种常见的发生于口腔黏膜上的溃疡性损伤病症,特点是反复发作、灼痛和各种并发症,溃疡数目由少到多,部位由前到后,溃烂面大如黄豆,小如米粒,表面附着白色溃烂腐膜。轻者可数月发生一次,重者间歇期逐渐缩短,逐年加重,甚至溃疡此起彼伏达数年、数十年不愈。临床上,口腔溃疡常采用患处局部给药方式,常用到的药物主要是西瓜霜喷剂、口腔溃疡凝胶等。其中口腔溃疡凝胶主要的作用是保护溃疡,并且药物成分促进溃疡愈合,防止溃疡被二次污染等。但口腔环境比较湿润,并容易因咀嚼、吞咽等活动而使药剂脱落,一般使得治疗效果深受影响。Oral ulcer is a common ulcerative injury disease that occurs on the oral mucosa. It is characterized by repeated attacks, burning pain and various complications. The number of ulcers increases from a few to a lot, and the location changes from front to back. The ulcer surface is as large as a soybean or as small as a grain of rice, and a white ulcerated film is attached to the surface. In mild cases, it may occur once every few months. In severe cases, the interval gradually shortens, and the ulcer becomes more severe year by year. Even ulcers may occur one after another for several years or even decades without healing. Clinically, oral ulcers are often treated by local administration of drugs to the affected area. The commonly used drugs are mainly watermelon frost spray, oral ulcer gel, etc. Among them, the main function of oral ulcer gel is to protect the ulcer, and the drug ingredients promote ulcer healing and prevent ulcers from being contaminated by secondary pollution. However, the oral environment is relatively moist, and it is easy for the drug to fall off due to activities such as chewing and swallowing, which generally affects the treatment effect.
贻贝粘蛋白,源于海洋生物紫贻贝的足丝腺。是一种易被人体吸收的高纯度单一蛋白质,该蛋白是唯一带正电荷大分子多巴基团生物材料,具备超强黏性,有效促进细胞贴壁爬行生长和创面愈合。研究表明,贻贝粘蛋白的强粘结性是由于蛋白质结构中的多巴与多巴氧化成的多巴醌,二者结构中的邻苯二酚之间形成的交联结构,使得贻贝可以牢牢粘附在礁石上,不惧海浪冲击。但是将贻贝粘蛋白直接应用在粘结剂中,所带来的最大问题就是,天然提取的贻贝粘蛋白量少且价格极其昂贵,通过重组蛋白表达系统得到的重组贻贝粘蛋白由于多巴的含量低,粘接性能不稳定。Mussel mucin originates from the foot gland of the marine organism blue mussel. It is a high-purity single protein that is easily absorbed by the human body. This protein is the only biomaterial with a positively charged macromolecular DOPA group. It has super strong viscosity and effectively promotes cell adhesion, crawling growth and wound healing. Studies have shown that the strong adhesion of mussel mucin is due to the cross-linking structure formed between DOPA in the protein structure and DOPA oxidized to DOPA quinone, and the catechol in the two structures, which allows mussels to adhere firmly to the reefs without fear of the impact of waves. However, the biggest problem with directly applying mussel mucin to adhesives is that the amount of naturally extracted mussel mucin is small and extremely expensive. The recombinant mussel mucin obtained by the recombinant protein expression system has unstable bonding properties due to the low DOPA content.
因此,通过邻苯二酚结构制备一种仿贻贝粘蛋白的且适用于口腔潮湿环境下的防水修复粘结剂,对改善羟乙基纤维素类粘结剂的口腔粘结性能具有重要应用的前景价值。Therefore, preparing a waterproof repair adhesive that imitates mussel mucin and is suitable for use in a humid oral environment through a catechol structure has important application prospects for improving the oral bonding properties of hydroxyethyl cellulose adhesives.
发明内容Summary of the invention
根据现有技术的不足,本发明通过碱作为催化剂,催化羟乙基纤维素上的环氧基开环得到碳正离子,左旋多巴作为亲核试剂以结构上的氨基进攻碳正离子,通过共价键的成键方式,使得左旋多巴结合到羟乙基纤维素;再通过醇作为桥联结构,使得左旋多巴上的羧基与脂肪酸通过醇进行连接固定,一方面通过左旋多巴结构上暴露在外的邻苯二酚之间的交联形成的网络结构,提高羟乙基纤维素在口腔的粘接性能;另一方面通过将脂肪酸上的疏水烷基链引入到环氧基团共价交联的左旋多巴上,通过疏水作用的团聚实现羟乙基纤维素的固化,既实现降低羟乙基纤维素溶胀率的目的,同时疏水的微环境阻止了邻苯二酚的氧化,提高了羟乙基纤维素的耐水性能,进而实现提高羟乙基纤维素的口腔粘结性能。具体地,本发明的技术方案包括以下内容:According to the deficiencies of the prior art, the present invention uses a base as a catalyst to catalyze the ring opening of the epoxy group on the hydroxyethyl cellulose to obtain a carbon cation, and levodopa is used as a nucleophilic reagent to attack the carbon cation with the amino group in the structure, so that levodopa is bound to the hydroxyethyl cellulose through the bonding method of covalent bonds; and then alcohol is used as a bridging structure, so that the carboxyl group on the levodopa and the fatty acid are connected and fixed through the alcohol, on the one hand, the network structure formed by the cross-linking between the catechol exposed on the levodopa structure is improved, and the bonding performance of hydroxyethyl cellulose in the oral cavity is improved; on the other hand, the hydrophobic alkyl chain on the fatty acid is introduced into the levodopa covalently cross-linked with the epoxy group, and the solidification of hydroxyethyl cellulose is achieved through the agglomeration of hydrophobic action, so as to achieve the purpose of reducing the swelling rate of hydroxyethyl cellulose, and at the same time, the hydrophobic microenvironment prevents the oxidation of catechol, improves the water resistance of hydroxyethyl cellulose, and thus improves the oral bonding performance of hydroxyethyl cellulose. Specifically, the technical scheme of the present invention includes the following contents:
一种仿贻贝粘蛋白的口腔修复粘结剂的制备方法,所述制备方法包括以下步骤:A method for preparing a mussel-mimicking oral repair adhesive, the preparation method comprising the following steps:
羟乙基纤维素与甘油混合并加热至45~50℃,再加入邻苯二酚衍生物与其混合搅拌形成反应体系;Hydroxyethyl cellulose and glycerin are mixed and heated to 45-50°C, and then catechol derivatives are added and mixed and stirred to form a reaction system;
向所述反应体系中加入碱性催化剂后,在60~70℃下反应时间2~4h得到混合物;After adding an alkaline catalyst to the reaction system, reacting at 60-70° C. for 2-4 hours to obtain a mixture;
所述混合物经与所述碱性催化剂的等量的盐酸处理后与脂肪酸、二元醇混合,再加入11.9~12mo l/L浓盐酸加热回流得到邻苯二酚-羟乙基纤维素衍生物;The mixture is treated with an equal amount of hydrochloric acid as the alkaline catalyst, mixed with fatty acid and diol, and then 11.9-12 mol/L concentrated hydrochloric acid is added and heated under reflux to obtain a catechol-hydroxyethyl cellulose derivative;
所述邻苯二酚-羟乙基纤维素衍生物与水性丙烯酸固化剂按照质量比3:1混合搅拌得到所述口腔修复粘结剂。The catechol-hydroxyethyl cellulose derivative and the aqueous acrylic curing agent are mixed and stirred in a mass ratio of 3:1 to obtain the oral restoration adhesive.
进一步地,所述邻苯二酚衍生物包括左旋多巴,所述邻苯二酚衍生物侧链碳链上需要连接有羧基和氨基,氨基作为亲电基团,向羟乙基纤维素上开环后的碳正离子发起亲核进攻,通过共价结合的方式结合到羟乙基纤维素上;而羧基则可以通过脱水缩合的方式与脂肪酸通过具有两个羟基的二元醇醇桥进行共价连接。Furthermore, the catechol derivatives include levodopa, and the side carbon chains of the catechol derivatives need to be connected with carboxyl groups and amino groups. The amino groups, as electrophilic groups, initiate nucleophilic attacks on the carbon cations after ring opening on the hydroxyethyl cellulose and are covalently bonded to the hydroxyethyl cellulose; while the carboxyl groups can be covalently bonded to the fatty acids through a diol bridge having two hydroxyl groups by dehydration condensation.
进一步地,所述羟乙基纤维素:甘油:邻苯二酚衍生物的质量比为1:1:0.5~1。Furthermore, the mass ratio of hydroxyethyl cellulose: glycerol: catechol derivative is 1:1:0.5-1.
进一步地,所述碱性催化剂包括氢氧化钠、氢氧化钾,所述碱性催化剂的用量为所述羟乙基纤维素质量的0.1~0.15。Furthermore, the alkaline catalyst includes sodium hydroxide and potassium hydroxide, and the amount of the alkaline catalyst used is 0.1 to 0.15 of the mass of the hydroxyethyl cellulose.
进一步地,所述脂肪酸包括饱和脂肪酸,所述饱和脂肪酸包括硬脂酸或软脂酸,不饱和脂肪酸可能由于结构上的碳碳双键产生了一定地位阻效应,降低了与邻苯二酚衍生物的连接成功率。Furthermore, the fatty acid includes a saturated fatty acid, and the saturated fatty acid includes stearic acid or palmitic acid. Unsaturated fatty acids may have a certain steric hindrance effect due to the carbon-carbon double bond in the structure, thereby reducing the success rate of connection with the catechol derivative.
进一步地,所述二元醇包括乙二醇或1,5-戊二醇,所述二元醇的羟基优选为碳链两端端基为羟基的二元醇,这样可以进一步地增加疏水链的长度。Furthermore, the diol includes ethylene glycol or 1,5-pentanediol, and the hydroxyl groups of the diol are preferably diols with hydroxyl groups at both ends of the carbon chain, which can further increase the length of the hydrophobic chain.
进一步地,所述脂肪酸的使用量为所述邻苯二酚衍生物质量的1~2倍,所述二元醇的使用量为所述脂肪酸质量的2~4倍。Furthermore, the amount of the fatty acid used is 1 to 2 times the mass of the catechol derivative, and the amount of the diol used is 2 to 4 times the mass of the fatty acid.
与现有技术相比,本发明的有益效果如下:Compared with the prior art, the present invention has the following beneficial effects:
(1)本发明通过碱催化羟乙基纤维素上的环氧基开环得到碳正离子,然后利用具有氨基结构的邻苯二酚衍生物左旋多巴作为亲核试剂,向羟乙基纤维素开环后得到的碳正离子结构发起亲核进攻,形成共价结合的交联网络结构,使得左旋多巴结合到羟乙基纤维素上,然后经盐酸处理,通过强酸制弱酸将左旋多巴因碱催化而使得结构上的邻苯二酚和羧基结合的钠离子除去,恢复邻苯二酚的活性效应和羧基的酸性;再通过具有两个羟基的二元醇作为醇桥,分别与邻苯二酚衍生物左旋多巴上的羧基和脂肪酸上的羧基通过脱水缩合形成共价键,将脂肪酸通过共价结合的桥联方式连接到邻苯二酚衍生物左旋多巴上,与左旋多巴形成共价交联的网状结构,脂肪酸通过与左旋多巴的连接而间接进入到羟乙基纤维素结构中,一方面利用具有类贻贝粘蛋白的左旋多巴结构上暴露在外的邻苯二酚之间形成的交联网状结构提高羟乙基纤维素在口腔的粘结性能,另一方面脂肪酸的疏水侧链通过共价交联结合到羟乙基纤维素上,通过疏水作用的团聚效应实现羟乙基纤维素的固化,既实现了降低羟乙基纤维素溶胀率的目的,同时疏水的微环境阻止了邻苯二酚的氧化,提高了羟乙基纤维素的耐水性能,左旋多巴上的邻苯二酚形成的交联网状结构与脂肪酸疏水侧链的协同效应,进一步地提高了羟乙基纤维素的口腔粘结性能。(1) The present invention uses base-catalyzed ring opening of the epoxy group on hydroxyethyl cellulose to obtain a carbon cation, and then uses the catechol derivative levodopa with an amino structure as a nucleophilic reagent to initiate a nucleophilic attack on the carbon cation structure obtained after the ring opening of hydroxyethyl cellulose, forming a covalently bonded cross-linked network structure, so that levodopa is bound to the hydroxyethyl cellulose, and then treated with hydrochloric acid to remove the sodium ions bound to the catechol and carboxyl groups on the structure of levodopa due to base catalysis by strong acid to weak acid, thereby restoring the active effect of catechol and the acidity of the carboxyl group; and then using a diol with two hydroxyl groups as an alcohol bridge to form a covalent bond with the carboxyl group on the catechol derivative levodopa and the carboxyl group on the fatty acid through dehydration condensation, so that the fatty acid is connected to the catechol derivative levodopa through a covalently bonded bridge. On the mussel mucin-like structure of levodopa, the fatty acid forms a covalently cross-linked network structure with levodopa, and the fatty acid indirectly enters the hydroxyethyl cellulose structure through the connection with levodopa. On the one hand, the cross-linked network structure formed between the catechols exposed on the levodopa structure is used to improve the bonding performance of hydroxyethyl cellulose in the oral cavity. On the other hand, the hydrophobic side chains of the fatty acids are bonded to the hydroxyethyl cellulose through covalent cross-linking, and the solidification of the hydroxyethyl cellulose is achieved through the agglomeration effect of the hydrophobic effect, which not only achieves the purpose of reducing the swelling rate of hydroxyethyl cellulose, but also prevents the oxidation of catechols by the hydrophobic microenvironment, thereby improving the water resistance of hydroxyethyl cellulose. The synergistic effect of the cross-linked network structure formed by the catechols on levodopa and the hydrophobic side chains of fatty acids further improves the oral bonding performance of hydroxyethyl cellulose.
(2)本发明构建的共价交联网络结构将疏水侧链引入到羟乙基纤维素中,使得羟乙基纤维素的吸水溶胀效应降低,获得了良好的溶胀率。(2) The covalently cross-linked network structure constructed by the present invention introduces hydrophobic side chains into hydroxyethyl cellulose, thereby reducing the water absorption and swelling effect of hydroxyethyl cellulose and obtaining a good swelling rate.
具体实施方式DETAILED DESCRIPTION
下面将通过本发明的实施例,对本发明的技术方案进行清晰、完整地描述,显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solution of the present invention will be clearly and completely described below through the embodiments of the present invention. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative work are within the scope of protection of the present invention.
除非另有说明,以下本发明中使用的原料和试剂均为市售商品,或者可以通过已知方法制备。Unless otherwise specified, the raw materials and reagents used in the present invention are commercially available or can be prepared by known methods.
实施例1:Embodiment 1:
一种仿贻贝粘蛋白的口腔修复粘结剂的制备方法,具体包括以下过程:A method for preparing a mussel-mimicking oral repair adhesive specifically comprises the following steps:
称取100g的羟乙基纤维素与100g的甘油混合放置于烧瓶中,加热至45℃后,再加入50g的左旋多巴与其混合搅拌直至左旋多巴完全溶解后,加入10g的氢氧化钠进行搅拌,将整个反应体系的温度控制在60℃下回流反应2h后,再加入10g的盐酸进行混合搅拌,然后加入过量的去离子水搅拌静置分层去除水相层,保留的有机相层与50g的硬脂酸和100g的乙二醇混合后,缓慢滴加10g的浓度为12mo l/L的浓盐酸,在60℃下回流2h的得到邻苯二酚-羟乙基纤维素衍生物;称取60g的邻苯二酚-羟乙基纤维素衍生物与20g的水性丙烯酸固化剂混合搅拌,得到口腔修复粘结剂。100 g of hydroxyethyl cellulose and 100 g of glycerol were weighed and mixed and placed in a flask. After heating to 45° C., 50 g of levodopa was added and mixed and stirred until the levodopa was completely dissolved, 10 g of sodium hydroxide was added and stirred, the temperature of the entire reaction system was controlled at 60° C. and refluxed for 2 hours, 10 g of hydrochloric acid was added and mixed and stirred, and then an excess of deionized water was added and stirred, and the aqueous phase layer was removed after standing for stratification. The retained organic phase layer was mixed with 50 g of stearic acid and 100 g of ethylene glycol, and 10 g of concentrated hydrochloric acid with a concentration of 12 mol/L was slowly added dropwise, and the mixture was refluxed at 60° C. for 2 hours to obtain a catechol-hydroxyethyl cellulose derivative; 60 g of the catechol-hydroxyethyl cellulose derivative was weighed and mixed with 20 g of an aqueous acrylic curing agent to obtain an oral restoration adhesive.
实施例2:Embodiment 2:
一种仿贻贝粘蛋白的口腔修复粘结剂的制备方法,具体包括以下过程:A method for preparing a mussel-mimicking oral repair adhesive specifically comprises the following steps:
称取100g的羟乙基纤维素与100g的甘油混合放置于烧瓶中,加热至46℃后,再加入60g的左旋多巴与其混合搅拌直至左旋多巴完全溶解后,加入12g的氢氧化钠进行搅拌,将整个反应体系的温度控制在64℃下回流反应2h后,再加入12g的盐酸进行混合搅拌,然后加入过量的去离子水搅拌静置分层去除水相层,保留的有机相层与72g的硬脂酸和180g的乙二醇混合后,缓慢滴加13.2g的浓度为12mo l/L的浓盐酸,在65℃下回流2h的得到邻苯二酚-羟乙基纤维素衍生物;称取60g的邻苯二酚-羟乙基纤维素衍生物与20g的制备例2中的水性丙烯酸固化剂混合搅拌,得到口腔修复粘结剂。100 g of hydroxyethyl cellulose and 100 g of glycerol were weighed and mixed and placed in a flask. After heating to 46° C., 60 g of levodopa was added and mixed and stirred until the levodopa was completely dissolved. 12 g of sodium hydroxide was added and stirred. The temperature of the entire reaction system was controlled at 64° C. and refluxed for 2 h. 12 g of hydrochloric acid was added and mixed and stirred. Then, an excess of deionized water was added and stirred, and the aqueous phase layer was removed by standing for stratification. The retained organic phase layer was mixed with 72 g of stearic acid and 180 g of ethylene glycol, and 13.2 g of concentrated hydrochloric acid with a concentration of 12 mol/L was slowly added dropwise. The mixture was refluxed at 65° C. for 2 h to obtain a catechol-hydroxyethyl cellulose derivative. 60 g of the catechol-hydroxyethyl cellulose derivative was weighed and mixed with 20 g of the water-based acrylic curing agent in Preparation Example 2 to obtain an oral repair adhesive.
实施例3:Embodiment 3:
一种仿贻贝粘蛋白的口腔修复粘结剂的制备方法,具体包括以下过程:A method for preparing a mussel-mimicking oral repair adhesive specifically comprises the following steps:
称取100g的羟乙基纤维素与100g的甘油混合放置于烧瓶中,加热至48℃后,再加入80g的左旋多巴与其混合搅拌直至左旋多巴完全溶解后,加入14g的氢氧化钾进行搅拌,将整个反应体系的温度控制在66℃下回流反应3h后,再加入14g的盐酸进行混合搅拌,然后加入过量的去离子水搅拌静置分层去除水相层,保留的有机相层与128g的软脂酸和448g的1,5-戊二醇混合后,缓慢滴加20.8g的浓度为12mo l/L的浓盐酸,在75℃下回流3h的得到邻苯二酚-羟乙基纤维素衍生物;称取60g的邻苯二酚-羟乙基纤维素衍生物与20g的制备例3中的水性丙烯酸固化剂混合搅拌,得到口腔修复粘结剂。100 g of hydroxyethyl cellulose and 100 g of glycerol were weighed and mixed and placed in a flask. After heating to 48° C., 80 g of levodopa was added and mixed and stirred until the levodopa was completely dissolved. 14 g of potassium hydroxide was added and stirred. The temperature of the entire reaction system was controlled at 66° C. and refluxed for 3 hours. 14 g of hydrochloric acid was added and mixed and stirred. Then, an excess of deionized water was added and stirred, and the aqueous phase layer was removed after standing for stratification. The retained organic phase layer was mixed with 128 g of palmitic acid and 448 g of 1,5-pentanediol, and 20.8 g of concentrated hydrochloric acid with a concentration of 12 mol/L was slowly added dropwise. The mixture was refluxed at 75° C. for 3 hours to obtain a catechol-hydroxyethyl cellulose derivative. 60 g of the catechol-hydroxyethyl cellulose derivative was weighed and mixed with 20 g of the aqueous acrylic curing agent in Preparation Example 3 to obtain an oral restoration adhesive.
实施例4:Embodiment 4:
一种仿贻贝粘蛋白的口腔修复粘结剂的制备方法,具体包括以下过程:A method for preparing a mussel-mimicking oral repair adhesive specifically comprises the following steps:
称取100g的羟乙基纤维素与100g的甘油混合放置于烧瓶中,加热至50℃后,再加入100g的左旋多巴与其混合搅拌直至左旋多巴完全溶解后,加入15g的氢氧化钾进行搅拌,将整个反应体系的温度控制在70℃下回流反应4h后,再加入15g的盐酸进行混合搅拌,然后加入过量的去离子水搅拌静置分层去除水相层,保留的有机相层与200g的软脂酸和100g的1,5-戊二醇混合后,缓慢滴加30g的浓度为12mo l/L的浓盐酸,在80℃下回流3h的得到邻苯二酚-羟乙基纤维素衍生物;称取60g的邻苯二酚-羟乙基纤维素衍生物与20g的制备例4中的水性丙烯酸固化剂混合搅拌,得到口腔修复粘结剂。100 g of hydroxyethyl cellulose and 100 g of glycerol were weighed and mixed and placed in a flask. After heating to 50° C., 100 g of levodopa was added and mixed and stirred until the levodopa was completely dissolved, and 15 g of potassium hydroxide was added for stirring. The temperature of the entire reaction system was controlled at 70° C. and refluxed for 4 hours. Then, 15 g of hydrochloric acid was added for mixing and stirring. Then, an excess of deionized water was added, stirred, and allowed to stand for stratification to remove the aqueous phase. The retained organic phase was mixed with 200 g of palmitic acid and 100 g of 1,5-pentanediol, and 30 g of concentrated hydrochloric acid with a concentration of 12 mol/L was slowly added dropwise. The mixture was refluxed at 80° C. for 3 hours to obtain a catechol-hydroxyethyl cellulose derivative. 60 g of the catechol-hydroxyethyl cellulose derivative was weighed and mixed with 20 g of the aqueous acrylic curing agent in Preparation Example 4 to obtain an oral repair adhesive.
对比例1:Comparative Example 1:
与实施例1的区别在于:不添加水性丙烯酸固化剂,其余不变。The difference from Example 1 is that no water-based acrylic curing agent is added, and the rest remains unchanged.
对实施例1~4和对比例1制备得到的口腔修复粘结剂进行玻璃塔接剪切性能测试,测试结果如下表:The oral repair adhesives prepared in Examples 1 to 4 and Comparative Example 1 were tested for glass tower shear performance. The test results are shown in the following table:
对实施例1~4和对比例1制备得到的口腔修复粘结剂放入PBS缓冲液中浸泡7天后,测定溶胀率,结果如下表:The oral repair adhesives prepared in Examples 1 to 4 and Comparative Example 1 were immersed in PBS buffer for 7 days, and the swelling rates were measured. The results are shown in the following table:
以上所述的实施例对比本发明的技术方案和有益效果进行了详细说明,应理解的是以上所述仅为本发明的具体实施例,并不用于限制本发明。在不脱离本发明精神和范围的前提下,本发明还会有各种变化和改进,包括反应条件的优化和反应比例的调整等,这些变化和改进都落入要求保护的本发明范围内。The above-described embodiments are described in detail in comparison with the technical solutions and beneficial effects of the present invention. It should be understood that the above is only a specific embodiment of the present invention and is not intended to limit the present invention. Without departing from the spirit and scope of the present invention, the present invention may also have various changes and improvements, including the optimization of reaction conditions and the adjustment of reaction ratio, and these changes and improvements all fall within the scope of the present invention claimed.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410693085.XA CN118697931A (en) | 2024-05-31 | 2024-05-31 | A kind of oral repair adhesive imitating mussel mucin and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410693085.XA CN118697931A (en) | 2024-05-31 | 2024-05-31 | A kind of oral repair adhesive imitating mussel mucin and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN118697931A true CN118697931A (en) | 2024-09-27 |
Family
ID=92820720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410693085.XA Pending CN118697931A (en) | 2024-05-31 | 2024-05-31 | A kind of oral repair adhesive imitating mussel mucin and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN118697931A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119220530A (en) * | 2024-12-04 | 2024-12-31 | 合肥贝壳派创新科技有限公司 | A bioenzyme catalyst for preparing mussel mucin and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100112053A1 (en) * | 2007-01-15 | 2010-05-06 | Kissei Pharmaceutical Co., Ltd. | Gastric retention-type sustained-release levodopa preparation |
US20170142975A1 (en) * | 2014-07-22 | 2017-05-25 | Celluforce Inc. | Polydopamine functionalized cellulose nanocrystals (pd-cncs) and uses thereof |
US20200071864A1 (en) * | 2017-05-11 | 2020-03-05 | Rockwool International A/S | Mineral wool binder |
US20230201101A1 (en) * | 2021-12-23 | 2023-06-29 | Colgate-Palmolive Company | Oral care complexes and compositions |
CN116920162A (en) * | 2022-03-31 | 2023-10-24 | 山东中医药大学 | Hydrogel composition, hydrogel, preparation method and application thereof |
CN117100692A (en) * | 2023-10-25 | 2023-11-24 | 常德市一诺生物医药有限公司 | Mussel mucin-added gel for repairing dental ulcer and preparation method thereof |
CN117339013A (en) * | 2023-12-04 | 2024-01-05 | 山东百多安医疗器械股份有限公司 | Hydrogel composite bracket capable of improving cartilage repair capability |
-
2024
- 2024-05-31 CN CN202410693085.XA patent/CN118697931A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100112053A1 (en) * | 2007-01-15 | 2010-05-06 | Kissei Pharmaceutical Co., Ltd. | Gastric retention-type sustained-release levodopa preparation |
US20170142975A1 (en) * | 2014-07-22 | 2017-05-25 | Celluforce Inc. | Polydopamine functionalized cellulose nanocrystals (pd-cncs) and uses thereof |
US20200071864A1 (en) * | 2017-05-11 | 2020-03-05 | Rockwool International A/S | Mineral wool binder |
US20230201101A1 (en) * | 2021-12-23 | 2023-06-29 | Colgate-Palmolive Company | Oral care complexes and compositions |
CN116920162A (en) * | 2022-03-31 | 2023-10-24 | 山东中医药大学 | Hydrogel composition, hydrogel, preparation method and application thereof |
CN117100692A (en) * | 2023-10-25 | 2023-11-24 | 常德市一诺生物医药有限公司 | Mussel mucin-added gel for repairing dental ulcer and preparation method thereof |
CN117339013A (en) * | 2023-12-04 | 2024-01-05 | 山东百多安医疗器械股份有限公司 | Hydrogel composite bracket capable of improving cartilage repair capability |
Non-Patent Citations (1)
Title |
---|
尹生妹: "改良耐水性纤维素纳米纤维胶粘剂的制备及应用研究", 中国胶黏剂, vol. 33, no. 1, 31 January 2024 (2024-01-31), pages 32 - 37 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119220530A (en) * | 2024-12-04 | 2024-12-31 | 合肥贝壳派创新科技有限公司 | A bioenzyme catalyst for preparing mussel mucin and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105477678B (en) | A kind of new bio adhesive of medical and preparation method thereof | |
KR900004316B1 (en) | Manufacturing method of hydrated gel | |
CN107158453B (en) | A kind of preparation method of hyaluronic acid tissue adhesive | |
CN118697931A (en) | A kind of oral repair adhesive imitating mussel mucin and preparation method thereof | |
CN106975097A (en) | A kind of bio-medical bonding hydrogel and preparation method thereof | |
CN104645320A (en) | Mussel mucoprotein gel for wound repair, and preparation method and application thereof | |
CN101455654B (en) | Arginine ibuprofen gel and preparation method thereof | |
CN115353647B (en) | A self-repairing marine collagen peptide-based composite hydrogel and its preparation method | |
CN118542964A (en) | A tissue sealant patch and preparation method thereof | |
CN103819685A (en) | Fish scale collagen grafted chitosan as well as preparation method and application thereof | |
CN118986863A (en) | External body gel for vulva and preparation method thereof | |
CN107049930A (en) | A kind of promoting healing wound gel and preparation method thereof | |
KR101424209B1 (en) | Natural adhesives comprising lacquer, and isinglass or animal glue and the method thereof | |
CN114524952B (en) | Preparation method of high-adhesion natural eggshell membrane chitosan hydrogel | |
CN106937941A (en) | A kind of medical skin diminishing inflammation of wound gel and preparation method thereof | |
CN106937942A (en) | A kind of medical skin wound analgesia gel and preparation method thereof | |
CN117100692A (en) | Mussel mucin-added gel for repairing dental ulcer and preparation method thereof | |
CN110075345B (en) | Bi-component self-adhesive gastric mucosa protective adhesive suitable for spraying gastroscope on surface of gastric injury mucosa and application thereof | |
CN113616850A (en) | A kind of highly transparent skin repairing hydrogel dressing and preparation method thereof | |
CN102349861B (en) | Phenolic acid modified collagen mask and preparation method thereof | |
Priyanka et al. | Study of secnidazole-serratiopeptidase alginate/HPMC gels for periodontal delivery | |
US12102729B2 (en) | Natural polymer-based tissue adhesive with healing-promoting properties | |
CN108714235A (en) | A kind of high bioactivity Propiram medical film and preparation method thereof based on the modification of low immunogenicity collagen | |
US11571492B2 (en) | Natural polymer-based tissue adhesive with healing-promoting properties | |
CN100500747C (en) | Film-forming gel compositions and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |